Eli Lilly Balance Sheet
NYSE: LLYHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Eli Lilly financial position
At the end of fiscal 2025, Eli Lilly reported total assets of $112.48 billion, up 42.9% from a year earlier against total liabilities of $85.94 billion. Shareholders' equity stood at $26.54 billion, or 23.6% of assets. The company held $7.27 billion in cash and equivalents against $42.50 billion of debt, a net debt position of $35.23 billion.
The current ratio (current assets divided by current liabilities) was 1.58, meaning short-term assets cover obligations due within a year. Debt-to-equity was 1.60.
Summary generated from market data by MetaCap's automated system. Methodology
Eli Lilly balance sheet (annual)
| Fiscal year (USD) | FY 20252025-12-31 | FY 20242024-12-31 | FY 20232023-12-31 | FY 20222022-12-31 | FY 20212021-12-31 | FY 20202020-12-31 | FY 20192019-12-31 | FY 20182018-12-31 | FY 20172017-12-31 | FY 20162016-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | 7.27B | 3.27B | 2.82B | 2.07B | 3.82B | 3.66B | 2.34B | 7.32B | 6.54B | 4.58B |
| Short-Term Investments | — | 154.80M | 109.10M | 144.80M | 90.10M | 24.20M | 101.00M | 88.20M | 1.50B | 1.46B |
| Receivables | 17.76B | 11.01B | 9.09B | 6.90B | 6.67B | 5.88B | 4.55B | 4.59B | 4.55B | 4.03B |
| Inventory | 13.74B | 7.59B | 5.77B | 4.31B | 3.89B | 3.98B | 3.19B | 3.10B | 4.46B | 3.56B |
| Total Current Assets | 55.63B | 32.74B | 25.73B | 18.03B | 18.45B | 17.46B | 13.71B | 20.55B | 19.20B | 15.10B |
| Property, Plant & Equipment | 24.68B | 17.10B | 12.91B | 10.14B | 8.99B | 8.68B | 7.87B | 8.00B | 8.83B | 8.25B |
| Goodwill | 5.90B | 5.77B | 4.94B | 4.07B | 3.89B | 3.77B | 3.68B | 1.37B | 4.37B | 3.97B |
| Intangible Assets | 6.52B | 6.17B | 6.91B | 7.21B | 7.69B | 7.45B | 6.62B | 1.07B | 4.03B | 4.36B |
| Long-Term Investments | 2.80B | 3.22B | 3.05B | 2.90B | 3.21B | 2.97B | 1.96B | 2.01B | 5.68B | 5.21B |
| Total Assets | 112.48B | 78.72B | 64.01B | 49.49B | 48.81B | 46.63B | 39.29B | 43.91B | 44.98B | 38.81B |
| Accounts Payable | 5.38B | 3.23B | 2.60B | 1.93B | 1.67B | 1.61B | 1.41B | 1.21B | 1.41B | 1.35B |
| Short-Term Debt | 1.64B | 5.12B | 6.90B | 1.50B | 1.54B | 8.70M | 1.50B | 1.10B | 3.71B | 1.94B |
| Total Current Liabilities | 35.23B | 28.38B | 27.29B | 17.14B | 15.05B | 12.48B | 11.78B | 11.89B | 14.54B | 10.99B |
| Long-Term Debt | 40.87B | 28.53B | 18.32B | 14.74B | 15.35B | 16.59B | 13.82B | 9.20B | 9.94B | 8.37B |
| Total Liabilities | 85.94B | 64.44B | 53.14B | 38.71B | 39.65B | 40.81B | 36.59B | 33.00B | 33.31B | 24.73B |
| Shareholders' Equity | 26.54B | 14.27B | 10.77B | 10.65B | 8.98B | 5.64B | 2.61B | 9.83B | 11.59B | 14.01B |
| Retained Earnings | 24.47B | 13.54B | 10.31B | 10.04B | 8.96B | 7.83B | 4.92B | 11.40B | 13.89B | 16.05B |
| Total Debt | 42.50B | 33.64B | 25.23B | 16.24B | 16.88B | 16.60B | 15.32B | 10.30B | 13.65B | 10.31B |
| Net Cash (Debt) | -35.23B | -30.22B | -22.30B | -14.03B | -12.98B | -12.91B | -12.88B | -2.89B | -5.61B | -4.27B |
This table shows 10 annual periods of Eli Lilly's balance sheet, from FY 2025 back to FY 2016, across 19 line items including cash & equivalents, short-term investments, receivables. Values in USD; B = billions, M = millions. Fiscal periods follow LLY's reporting calendar. What is a balance sheet?